The NCI SBIR Development Center is piloting a program to encourage communications between small businesses and the FDA. Eligibility is open to NCI SBIR/STTR-funded small businesses that are developing potential technologies under the regulatory authority of FDA, including Center for Biologics Evaluation and Research (CBER), Center for Drug Evaluation and Research (CDER), and Center for Devices and Radiological Health (CDRH). This program is intended for early-stage companies that have not discussed their technology with FDA or participated in the CARE program previously. The deadline for applications is December 11, 2020.
For more information, please contact Monique Pond (email@example.com).